First-in-Human Study of OKI-219 Alone and in Combination with Other Therapies in Patients with Solid Tumors / Breast Cancer

What you commit to

• Study type: Interventional · Phase 1
• Planned participants: 145
• 20 sites in 4 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Sites (20)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details